Can You Take Wegovy Once a Month? What the Schedule Actually Looks Like

Each Wegovy pen contains four weekly doses, one pen lasts approximately four weeks, not one injection per month.
The dosing schedule is once every seven days, at roughly the same time each week, and the day can be chosen to suit your routine.
Treatment follows a step-up path, typically 0.25 mg rising through 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg, each step is usually held for about four weeks before the prescriber reviews progress.
Missing a dose, or spacing doses incorrectly, is a clinical matter: the Wegovy Patient Information Leaflet and your prescriber are the right sources for what to do in that situation.

No — Wegovy is a once-weekly injection, not a monthly one. Each pre-filled pen contains four doses and is used one dose at a time, every seven days, on a day that suits you. The monthly packaging is where the confusion tends to come from. Because each pen lasts roughly four weeks, some people read "one pen" as "one jab" — that's the mix-up this page unpicks. Wegovy (semaglutide) is a prescription-only medicine; a prescriber assesses whether it's clinically appropriate before treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why the once-weekly schedule matters and what it means for your treatment

The myth: one pen, one injection, corrected

The most common source of this confusion is the way Wegovy is supplied. You receive a single KwikPen, and it covers roughly a month of treatment, so at a glance it can look like a once-monthly medicine. It isn't. The pen is designed to deliver four separate weekly doses, each dialled and injected seven days apart. Thinking of it as a monthly jab and stretching doses out would mean going weeks without semaglutide in your system, which is not how the medicine is studied or licensed to work.

The NHS medicines page for semaglutide is clear that Wegovy is a once-weekly injection. If you've seen the term "monthly" used on a website selling weight-loss medication, treat that as a red flag about the source rather than a fact about the medicine.

A quick practical note: once you've picked your injection day, it's worth anchoring it to something fixed in your week. A lot of people pick Sunday evening, or the same weekday morning. That consistency is easier to maintain than trying to count seven days each time.

How the weekly dosing builds over months of treatment

Wegovy's schedule is gradual by design. Treatment opens at 0.25 mg (a dose chosen to settle your system, not yet at a therapeutic level) and the prescriber typically moves through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance dose, spending around four weeks at each stage. The MHRA also approved a 7.2 mg maintenance dose in January 2026, with a dedicated single-dose pen following in April 2026 for adults with a BMI of 30 or above.

What this means in practice is that your first few months on Wegovy are about adjustment as much as weight loss. Month two looks different from month one; month three is different again. If you're curious about what those early stages typically involve, our page on month two of Wegovy treatment and what tends to happen in month three walk through the clinical picture in more detail.

The STEP 1 trial (published in the New England Journal of Medicine) ran for 68 weeks and found an average weight reduction of around 15% at the 2.4 mg dose. That result reflects consistent weekly dosing across the full period alongside lifestyle changes, not a shortened or interrupted schedule.

What happens if you miss a dose or try to stretch the interval?

This is a question our prescribers hear regularly. Spacing doses out beyond seven days (whether intentionally or because a pen is delayed) is not the same as the studied schedule, and the right course of action depends on how much time has passed. That detail belongs in the Wegovy Patient Information Leaflet and your prescriber's hands, not on an information page. The short version: don't try to guess, and don't double-dose. Contact whoever prescribed your treatment.

The broader point is that Wegovy is a prescription medicine precisely because questions like this require clinical input. If you're wondering whether it's right for you in the first place, our Wegovy overview covers licensing, eligibility, and how semaglutide works, a useful starting point before a consultation. You can also read more about the once-weekly dosing structure if you want a fuller picture of the schedule in practice.

How cost factors in, and what a monthly price actually covers

Private Wegovy pricing is quoted per pen, which covers roughly four weeks. That framing can reinforce the "once a month" impression. To be clear: the price you see is for one pen containing four weekly doses, not for a single injection.

Understanding what a monthly cost does and doesn't include is worth doing carefully. Some providers quote a headline pen price and add consultation and prescription fees separately; others include aftercare as an optional extra. On our treatment page, the price shown covers the consultation, prescription, the medicine itself, and next-working-day tracked delivery, no separate fees for those elements. For broader context on how Wegovy pricing works in the UK private market, our buying guide runs through what to look for.

Wegovy's cost is also worth considering alongside alternatives. If you're comparing semaglutide with other licensed options, our comparison of Wegovy and its competitors covers the clinical and practical differences. And if you're early in your research and want a wider view of weight-loss treatment options, that's a good place to take stock.

For a full overview of semaglutide as a medicine (the mechanism, the evidence, the side-effect profile) our semaglutide page pulls the key facts together. When you're ready to find out whether Wegovy is clinically suitable for you, start your free consultation and a GPhC-registered prescriber will review your answers the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions